Log In
Print
BCIQ
Print
Print this Print this
 

CHR-5154

  Manage Alerts
Collapse Summary General Information
Company Chroma Therapeutics Ltd.
DescriptionMacrophage-targeted histone deacetylase (HDAC) inhibitor
Molecular Target Histone deacetylase (HDAC)
Mechanism of ActionHistone deacetylase (HDAC) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Inflammation (unspecified)
Indication DetailsTreat inflammatory diseases
Regulatory Designation

Partner

GlaxoSmithKline plc


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today